APA (7th ed.) Citation

Chrovian, C. C., Soyode-Johnson, A., Peterson, A. A., Gelin, C. F., Deng, X., Dvorak, C. A., . . . Letavic, M. A. (2018). A Dipolar Cycloaddition Reaction To Access 6‑Methyl-4,5,6,7-tetrahydro‑1H‑[1,2,3]­triazolo[4,5‑c]­pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate. Journal of medicinal chemistry, 61(1), 207-223. https://doi.org/10.1021/acs.jmedchem.7b01279

Chicago Style (17th ed.) Citation

Chrovian, Christa C., et al. "A Dipolar Cycloaddition Reaction To Access 6‑Methyl-4,5,6,7-tetrahydro‑1H‑[1,2,3]­triazolo[4,5‑c]­pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate." Journal of Medicinal Chemistry 61, no. 1 (2018): 207-223. https://doi.org/10.1021/acs.jmedchem.7b01279.

MLA (9th ed.) Citation

Chrovian, Christa C., et al. "A Dipolar Cycloaddition Reaction To Access 6‑Methyl-4,5,6,7-tetrahydro‑1H‑[1,2,3]­triazolo[4,5‑c]­pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate." Journal of Medicinal Chemistry, vol. 61, no. 1, 2018, pp. 207-223, https://doi.org/10.1021/acs.jmedchem.7b01279.